Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.
Clinical trial NCT07064330 · RECRUITING
Trial details
- NCT number
- NCT07064330
- Sponsor
- Instituto de Investigación Biomédica de Salamanca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-17
- Primary completion
- 2027-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.